{'Year': '2009', 'Month': 'Jun'}
Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.
To demonstrate how several polymorphisms previously associated with the efficacy of the novel antipsychotic iloperidone could be used together to predict clinical response and provide practical information for individualized treatment.